Nuburu Stock Price, News & Analysis

NUBURU, a leading innovator in industrial blue laser technology, announced a 1-for-40 reverse stock split of its common stock, aiming for July 1, 2024, to improve marketability and liquidity. Initially planned for June 24, 2024, the split was delayed due to NYSE halting trading on the first announcement. NUBURU is appealing the NYSE's decision to delist its stock, currently traded over-the-counter as 'BURU'. Post-split, the stock will trade under the same symbol with a new CUSIP number, 67021W301. CEO Brian Knaley emphasized the move's strategic importance for attracting institutional investors and returning to NYSE American. However, the success of the appeal and meeting NYSE's bid price requirements remain uncertain, potentially impacting liquidity, market price, and the ability to raise equity financing.

NUBURU, a leader in industrial blue laser technology, has announced plans to appeal the NYSE's decision to delist its common stock. The NYSE cited that the company's stock is no longer suitable for listing as its bid price fell below $0.10, in accordance with Section 1003(f)(v) of the NYSE American Company Guide. Effective June 14, 2024, FINRA has assigned the symbol “BURU” for NUBURU's stock to be traded in the over-the-counter (OTC) market. CEO Brian Knaley emphasized the company's ongoing efforts to reduce debt, raise capital, secure new orders, and receive industry recognitions despite the delisting notice. NUBURU remains committed to strengthening relationships with shareholders, financing partners, employees, customers, and vendors to enhance its business plan and increase shareholder value.

NUBURU, a leader in high-power blue laser technology, shared a letter from CEO Brian Knaley outlining strategic realignments and growth milestones. The company has increased orders, reduced debt by 25%, and plans a 1-for-40 reverse stock split effective June 24, 2024, to maintain NYSE listing and appeal to institutional investors. NUBURU holds over 220 patents and continues to innovate with products like the AO-650 and BL series lasers. The company is focused on reducing carbon emissions and improving manufacturing efficiency. Future plans include expanding their workforce and investing in R&D to maintain industry leadership and open new markets.

NUBURU has received a purchase order from Blueacre Technology, a European medical device manufacturer, for its BlueScan solution. The blue laser technology will be used for precision welding in medical devices, leveraging its ability to work with various metals and reduce heat damage. This move expands NUBURU's market focus beyond electric vehicles to include medical devices, a sector worth $6 billion. The order follows NUBURU's Phase II contract with NASA to advance blue laser power transmission technology for space applications.

NUBURU, Inc. announced a $850,000 Phase II contract with NASA to advance blue laser power transmission technology, aiming to reduce the size and weight of equipment for Lunar and Martian applications. The technology provides a unique solution to power beaming, aligning with NASA's Artemis program goals. NUBURU aims to scale up the power and range of the blue laser technology in this program, potentially revolutionizing power management in space and commercial sectors.